(IN KÜRZE) Die University of Liverpool und die Global Antibiotic Research and Development Partnership (GARDP) haben eine Absichtserklärung unterzeichnet, um bei neuen Projekten zur Bekämpfung der Antibiotikaresistenz (AMR) zusammenzuarbeiten. Sie arbeiten seit 2018 zusammen, um neue Behandlungsmöglichkeiten für Neugeborene mit … Read the full press release
Posted in Education, Healthcare, Non Profit, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged AMR, Antimikrobielle Chemotherapie-Konferenz, antimikrobielle Resistenz, arzneimittelresistente Infektionen, Arzneimittelresistenz, Dame Sally Davies, GARDP, Global Antibiotic Research and Development Partnership, Neugeborene, Professor William Hope, Seamus O’Brien, SEPSIS, the University of Liverpool
(IN BRIEF) The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR). They have been working together since 2018 to advance … Read the full press release
Posted in Education, Healthcare, Non Profit, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged AMR, Antimicrobial Chemotherapy Conference, antimicrobial resistance, Dame Sally Davies, drug resistance, drug-resistant infections, GARDP, Global Antibiotic Research and Development Partnership, newborns, Professor William Hope, Seamus O’Brien, SEPSIS, the University of Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
